Heron Therapeutics (HRTX) EBIT Margin (2010 - 2026)
Heron Therapeutics (HRTX) reported EBIT Margin of -5.43% for Q2 2026, down 1.03 percentage points from -4.40% a year earlier but up 8.30 percentage points from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) EBIT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Heron Therapeutics' EBIT Margin came in at -7.19%, down 8.01 percentage points year-over-year; for FY2025, it was -1.64%, up 6.35 percentage points from FY2024.
- EBIT Margin has increased for five consecutive years, with a five-year change of +255.77 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -7.99% in FY2024 (+79.08 pp), -87.07% in FY2023 (+75.14 pp), -162.21% in FY2022 (+90.06 pp) and -252.27% in FY2021 (+5.14 pp).
- Five-year quarterly EBIT Margin spans a low of -268.25% in Q1 2022 and a high of 10.23% in Q4 2024.
- Year over year, EBIT Margin has now declined in each of the last three quarters, with an average year-over-year change of +13.89 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q4 2022 (a gain of 191.41 percentage points); the low point was Q1 2026 (a drop of 21.83 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -13.73% (Q1 2026), 0.09% (Q4 2025) and -10.71% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn | -5.43% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.43% |
| Mar 31, 2026 | -13.73% |
| Dec 31, 2025 | 0.09% |
| Sep 30, 2025 | -10.71% |
| Jun 30, 2025 | -4.40% |
| Mar 31, 2025 | 8.11% |
| Dec 31, 2024 | 10.23% |
| Sep 30, 2024 | -13.59% |
| Jun 30, 2024 | -17.89% |
| Mar 31, 2024 | -13.84% |
| Dec 31, 2023 | -29.85% |
| Sep 30, 2023 | -79.31% |
| Jun 30, 2023 | -133.50% |
| Mar 31, 2023 | -111.64% |
| Dec 31, 2022 | -67.79% |
| Sep 30, 2022 | -157.71% |
| Jun 30, 2022 | -179.15% |
| Mar 31, 2022 | -268.25% |
| Dec 31, 2021 | -259.20% |
| Sep 30, 2021 | -222.59% |
API Access
Heron Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();